CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023		406,387
Beginning balance at Dec. 31, 2023	$ 661,021	$ 4,064	$ 1,986,899	$ (1,326,826)	$ (2,298)	$ (818)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(154,311)			(154,361)		50
Other comprehensive income (loss)	2,599				2,599
Exercise of stock options (in shares)		1,508
Exercise of stock options	2,758	$ 15	2,743
Vesting of restricted stock units (in shares)		2,409
Vesting of restricted stock units	0	$ 24	(24)
Shares withheld related to net share settlement (in shares)		(318)
Shares withheld related to net share settlement	(1,568)	$ (3)	(1,565)
Issuance of common stock (in shares)		1,974
Issuance of common stock	15,230	$ 20	15,210
Stock-based compensation expense	48,375		48,375
Dissolution of partially owned entity	768					768
Ending balance, (in shares) at Sep. 30, 2024		411,960
Ending balance at Sep. 30, 2024	574,872	$ 4,120	2,051,638	(1,481,187)	301	0
Beginning balance (in shares) at Jun. 30, 2024		411,447
Beginning balance at Jun. 30, 2024	675,867	$ 4,114	2,038,540	(1,363,572)	(2,447)	(768)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(117,615)			(117,615)
Other comprehensive income (loss)	2,748				2,748
Exercise of stock options (in shares)		32
Exercise of stock options	132		132
Vesting of restricted stock units (in shares)		549
Vesting of restricted stock units	0	$ 7	(7)
Shares withheld related to net share settlement (in shares)		(68)
Shares withheld related to net share settlement	(287)	$ (1)	(286)
Stock-based compensation expense	13,259		13,259
Dissolution of partially owned entity	768					768
Ending balance, (in shares) at Sep. 30, 2024		411,960
Ending balance at Sep. 30, 2024	$ 574,872	$ 4,120	2,051,638	(1,481,187)	301	$ 0
Beginning balance (in shares) at Dec. 31, 2024	412,194	412,194
Beginning balance at Dec. 31, 2024	$ 470,952	$ 4,122	2,053,895	(1,586,977)	(88)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(202,465)			(202,465)
Other comprehensive income (loss)	968				968
Exercise of stock options (in shares)		24
Exercise of stock options	110		110
Vesting of restricted stock units (in shares)		3,021
Vesting of restricted stock units	0	$ 30	(30)
Shares withheld related to net share settlement (in shares)		(669)
Shares withheld related to net share settlement	(3,087)	$ (6)	(3,081)
Stock-based compensation expense	$ 39,599		39,599
Ending balance, (in shares) at Sep. 30, 2025	414,570	414,570
Ending balance at Sep. 30, 2025	$ 306,077	$ 4,146	2,090,493	(1,789,442)	880
Beginning balance (in shares) at Jun. 30, 2025		414,283
Beginning balance at Jun. 30, 2025	408,929	$ 4,143	2,083,234	(1,679,235)	787
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(110,207)			(110,207)
Other comprehensive income (loss)	93				93
Vesting of restricted stock units (in shares)		417
Vesting of restricted stock units	0	$ 4	(4)
Shares withheld related to net share settlement (in shares)		(130)
Shares withheld related to net share settlement	(236)	$ (1)	(235)
Stock-based compensation expense	$ 7,498		7,498
Ending balance, (in shares) at Sep. 30, 2025	414,570	414,570
Ending balance at Sep. 30, 2025	$ 306,077	$ 4,146	$ 2,090,493	$ (1,789,442)	$ 880